• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problems Crack (1135); Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/15/2019
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction photoactivation module leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot h108 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot h108 for the reported issue shows no trends.Trends were reviewed for complaint category, photoactivation module leak.No trends were detected for this complaint category.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned photographs and smart card is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).
 
Event Description
The customer contacted mallinckrodt to report they experienced a photoactivation module leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.Approximately 1120 ml of whole blood was processed at the time the leak was observed.According to the customer, foam was observed in the kit's treatment bag at the end of the photoactivation phase.The ecp treatment was paused and the kit's photoactivation module was removed from the cellex instrument's photoactivation chamber for inspection.Cracks in the kit's photoactivation module and a fluid leak were discovered upon completion of the inspection.The ecp treatment was aborted and no residual blood within the kit was returned to the patient.The patient was re-scheduled to receive their ecp treatment the following day.The customer has provided photographs and the kit's smart card data for investigation.
 
Manufacturer Narrative
Photographs of the complaint kit and the smart card data was returned for evaluation.A review of the smart card data shows the treatment proceeded to the buffy coat collection phase after 1025 ml of whole blood was processed.Photoactivation was completed and then the operator aborted the treatment.Examination of the provided photographs cannot verify the photoactivation module leak; however, show a large amount of foam and air in the treatment bag.The air in the treatment bag is consistent with a photoactivation module leak allowing air to enter the module.An additional photograph shows cracks running across the channel in the photoactivation module.A known cause for cracks in the photoactivation module is due to excessive solvent used during manufacturing.The solvent can cause damage to the photoactivation plate if too much solvent is used and left to set within the plate.It appears the excess solvent is from the bond that joins the black stripe tubing to the port on the photoactivation plate.The root cause of the cracks in the photoactivation plate is most likely due to excessive solvent during the tube bonding process by the manufacturing operator.Retraining has been completed for the affected operators on 06 sep 2019.No further action is required at this time.This investigation is now complete.Mc: 044282.P.T.10/08/2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC.
bedminster NJ 07921
MDR Report Key9030612
MDR Text Key193966335
Report Number2523595-2019-00105
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/01/2021
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXECP
Device Lot NumberH108
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/15/2019
Initial Date FDA Received09/13/2019
Supplement Dates Manufacturer Received09/18/2019
Supplement Dates FDA Received10/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age6 YR
Patient Weight25
-
-